Miacalcin is commonly prescribed to treat a variety of conditions. It comes in nasal spray and injectable forms. The nasal spray is used for treating osteoporosis in women who are at least five years past menopause. The injectable form is approved to treat hypercalcemia, Paget's disease, and osteoporosis in postmenopausal women. Potential side effects include nausea, vomiting, and back pain.
What Is Miacalcin?
Miacalcin® (calcitonin) is a prescription medication available as a nasal spray or as an injection. The injectable form is approved to treat the following conditions:
Miacalcin is a manufactured version of calcitonin, a naturally occurring hormone that helps regulate bone formation and breakdown. It is actually a synthetic version of calcitonin from salmon (known as calcitonin salmon), which is more potent and longer-acting than human calcitonin. Miacalcin also appears to have some activity as a pain reliever, independent of its effects on bone.
The medication works to decrease blood calcium in several ways. First, it slows down the rate at which bone breaks down, which decreases the release of calcium from bone. Second, it increases the ability of the kidneys to excrete calcium into the urine, which helps clear calcium from the blood.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed December 12, 2008.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 7th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2005.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click